Kolon Life Science Inc Cash Flow Quality Index
Kolon Life Science Inc cash flow quality index. Kolon Life Science Inc (102940) has a Cash Flow Quality Index of 0.10x as of September 2025. Operating cash flow of ₩2.58 Billion is below net income of ₩25.54 Billion, suggesting accrual-heavy earnings not yet converted to cash. See Kolon Life Science Inc (102940) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Kolon Life Science Inc (2011–2022)
Cash flow quality index of Kolon Life Science Inc from 2011 to 2022. Historical Cash Flow Quality Index for Kolon Life Science Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Kolon Life Science Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Kolon Life Science Inc Cash Flow Quality Index by Year (2011–2022)
Kolon Life Science Inc cash flow quality index by year from 2011 to 2022. Year-by-year earnings quality comparison for Kolon Life Science Inc. For the full cash flow conversion analysis, see 102940 cash generation efficiency.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -9.78x | ₩-20.85 Billion | ₩2.13 Billion | ▼ -540.4% |
| 2016 | 2.22x | ₩28.11 Billion | ₩12.67 Billion | ▼ -91.5% |
| 2015 | 26.00x | ₩20.81 Billion | ₩800.14 Million | ▲ +1158.9% |
| 2014 | 2.07x | ₩12.10 Billion | ₩5.86 Billion | ▲ +67.1% |
| 2012 | 1.24x | ₩23.37 Billion | ₩18.90 Billion | ▲ +18.5% |
| 2011 | 1.04x | ₩11.65 Billion | ₩11.17 Billion | — |